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ture, pharmaco-acupuncture, Chuna and oral administration
of herbal medicines (Gangchuk tang) everyday during about
one month of admission treatment. Zero to ten pain numer-
ating rating scale (NRS) of low back pain and sciatica, walking
duration without claudication symptom before and after
treatment.
Results:Atotal of 7 patients’ (average 67 years old, [53 to 78])
medical records were included into the analysis. Segmental
degenerative change at lower and upper level of the spine was
observed at average 7.64 (4.51) years after the fusion surgery.
Average zero to ten NRS of low back pain was improved from
6.57 (SD 2.23) to 2.71 (2.06). Walking duration without pain
increased from 118.57m (171.02) to 771.43m (1029.25). There
was no adverse event related to the treatment.
Conclusion:ConservativeKoreanmedicinal treatmentmay
be effective for the symptom management of adjacent seg-
ment syndrome after spinal fusion surgery. Future long-term
randomized trials with active control intervention, enough
sample size and validated outcomes will be necessary for con-
crete clinical evidence of this treatment program.
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Purpose: To assess effectiveness of non-surgical combina-
tion treatments on the symptoms related to spondylolisthesis.
Methods: This is a retrospective audit study. Mokhuri spine
center is a department of Mokhuri oriental medical hospital,
located in Seoul, South Korea. We reviewed all the patients’
medical records, diagnosed as spondylolisthesis and partici-
pated in the admission treatment program from January, 2013
to March, 2014. All the patients took conservative integrative
treatments. Body acupuncture, pharmacopuncture, Chuna
and oral administration of herbal medicines were offered to
every patient each day. Zero to ten pain numerating rating
scale (NRS) of low back pain, walking distance without pain
were assessed before and after treatment. If available, func-
tional assessment with Oswestry disability index (ODI) and
quality of life with EQ-5D were evaluated. Statistical analysis
between the variables of before and after treatment was con-
ducted with t-test or Wilconxon signed rank test using SAS
9.2 package software. Spearman correlation was analyzed to
assess the statistical dependence between baseline character-
istics and main outcome variables.
Results: A total 44 spondylolisthesis patients’ medical
records were reviewed. Disease durations were average 23.1
month (SD 52.8). After average 24.0 days (SD 6.5) of treatments,
pain NRS improved from 7.1 (SD 2.0) to 3.1 (SD 1.9) signiﬁ-
cantly (t-test, p<0.0001). Walking distance showed signiﬁcant
improvement after treatment (193m (SD 234) at the beginning
and 568m (SD 514) after treatment, Wilcoxon test, p<0.0001).
ODI improved from 44.7 (SD 17.7) to 31.0 (SD 16.5) (n=13, t-test,
P=0.00017). EQ-5D also improved signiﬁcantly (n=12, Wilcoxon
test, p=0.00195). From the correlation test, we found thatwhen
disease duration increases, the improvement of lumbar func-
tion and quality of life decrease respectively. There was no
reported adverse event related to the treatments.
Conclusion: We found that conservative integrative treat-
ments might be effective in the patients with spondylolisthe-
sis.
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Purpose: This case report presents the effects of Korean
medicine therapy of Gunchilgyebok-Wan to a patient who was
clinicaly diagnosed as both stage III lung cancer and benign
hamartoma.
Methods: A 74-year-old male patient was clinicaly diag-
nosed as both stage III lung cancer and benign hamartoma by
chest computed tomography (CT), positron emission tomogra-
phy (PET) CT. Because of old age and general body weakness,
he had refused to receive standard cancer treatment regi-
men, percutaneous needle aspiration (PCNA) and biopsy. The
11.32mm and 23.03mm× 35.34mm sized masses were on
the right upper lobe of lung and in the mediastinum respec-
tively. The paitient’s chief complaints were fatigue, itching,
anorexia, cough and sputum. Gunchilgyebok-Wan commonly
used for anti-tumor and anti-inﬂammatory effect is com-
posed of Lacca sinica extract and Guì zhı¯ fúlíng wán extract
which has Cinnamomi Ramulus, Hoelen etc. We prescribed
Gunchilgyebok-wan 1g a dosage three times a day for 50 days.
Then we identiﬁed the decrease in tumor sizes by chest CT.
Results: Decrease in tumor size on the chest CT
and improvement of symptoms were observed after the
administration of Gun chilgyebok-Wan. The Right lung
upper lobe mass size was decreased from 11.32mm to
10.69mm and mediastinum mass size was deceased from
23.03mm× 35.34mm to 22.71mm ×34.21mm in 3 months.
Numerical rating scale (NR S) showed improvement in Fatigue,
weakness, itching and anorexia symptoms from point 7-8 to
point 3-4. Sputum and cough were slightly improved. Kidney
function test and complete blood cell count were in normal
range. Liver function test showed slight increase than normal
range at hospitalization day but gradually decreased during
treatment. Tumor markers were slightly elevated from hos-
pitalization day, but further tests should have been carried
out.
